Long-acting injectable formulation technologies: challenges and opportunities for the delivery of fragile molecules-Reference-Cited by-同舟云学术

Long-acting injectable formulation technologies: challenges and opportunities for the delivery of fragile molecules

Published:2022-07-28 Issue:8 Volume:19 Page:927-944
ISSN:1742-5247
Container-title:Expert Opinion on Drug Delivery
language:en
Short-container-title:Expert Opinion on Drug Delivery

Author:

Gonella Andrea¹,Grizot Sylvestre¹,Liu Fang¹,López Noriega Adolfo¹,Richard Joël¹

Affiliation:

1. MedinCell S.A, Jacou, France

Publisher

Informa UK Limited

Subject

Pharmaceutical Science

Link

https://www.tandfonline.com/doi/pdf/10.1080/17425247.2022.2105318

Reference158 articles.

1. Recent advances in (therapeutic protein) drug development

2. What Are “Biologics” Questions and Answers | FDA [Internet]. cited 2021 Sep 9. Available from: https://www.fda.gov/about-fda/center-biologics-evaluation-and-research-cber/what-are-biologics-questions-and-answers

3. Non-invasive delivery strategies for biologics

4. PepTherDia: database and structural composition analysis of approved peptide therapeutics and diagnostics

5. Biologics vs. small molecules: Drug costs and patient access

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Long acting injectables for the treatment of prostate cancer;Journal of Drug Delivery Science and Technology;2024-10

2. Patient-Centric Long-Acting Injectable and Implantable Platforms─An Industrial Perspective;Molecular Pharmaceutics;2024-08-19

3. Computational Approaches for Drug Delivery of Nanoparticles;Drug Delivery Systems Using Quantum Computing;2024-07

4. Injectable long-acting formulations (ILAFs) and manufacturing techniques;Expert Opinion on Drug Delivery;2024-06-02

5. Peptide Acylation in Aliphatic Polyesters: a Review of Mechanisms and Inhibition Strategies;Pharmaceutical Research;2024-03-19